Davis Polk advised the sales agent on the offering.
ImmunityBio, Inc. executed an at-the-market offering of its common stock for up to an aggregate amount of $500 million.
Based in Los Angeles, California, ImmunityBio, Inc. is an immunotherapy company working to advance the next-generation of immunotherapies and to address unmet needs within oncology and infectious disease.
The Davis Polk corporate team advising Jefferies included partner Alan F. Denenberg (Picture) and associates Bryan M. Quinn and Lawrence Edward Traylor Jr. The intellectual property and technology transactions team included partner David R. Bauer and associate Brette L. Trost. Counsel Marcie A. Goldstein provided FINRA advice.
Involved fees earner: David Bauer – Davis Polk & Wardwell; Alan Denenberg – Davis Polk & Wardwell; Marcie Goldstein – Davis Polk & Wardwell; Bryan Quinn – Davis Polk & Wardwell; Lawrence Edward Traylor Jr. – Davis Polk & Wardwell; Brette Trost – Davis Polk & Wardwell;
Law Firms: Davis Polk & Wardwell;